Korean pharma company targets regenerative medic
Author: Michael
Milan panel explores how longevity medicine is s
Sam Altman-backed longevity startup moves deeper
European platform ties biomarker data to clinica
New trial data suggest Eli Lilly’s next-gen we
Retro Biosciences, a leading biotechnology compan
Emagene.
HCW Biologics completed a $4 million private plac
TreeFrog Therapeutics will present new preclinica
Open-source system uses adversarial AI workflows